The four filings linked here all carry the applicant name Fujifilm Corporation, with a Minato-Ku, Tokyo filing address and a contact listed through Fujifilm Healthcare Americas Corporation. All four are Traditional 510(k)s reviewed by the Radiology panel, and all four closed with a substantially equivalent decision. Two product codes appear: LNH for magnetic resonance diagnostic devices under 21 CFR 892.1000, and JAK for computed tomography x-ray systems under 21 CFR 892.1750. The records describe cleared device identities and review scope, not commercial performance. [1][2][3][4]
Magnetic resonance filings
ECHELON Synergy, filed as K262902, was received on August 18, 2026 and decided on October 9, 2026 as substantially equivalent under product code LNH. APERTO Lucent MRI System, filed as K261283, was received on April 17, 2026 and decided on September 16, 2026, also under LNH. Both records list the device description as a nuclear magnetic resonance imaging system, Class II, regulation 892.1000, with a summary statement included. [1][3]
ECHELON Synergy clearance K241429 was issued on August 13, 2024 to FUJIFILM Healthcare Corporation, a differently named applicant on that letter. The K251386 document identifies the ECHELON Synergy MRI System cleared under K241429 as a predicate device. Those earlier filings have their own applicant names and decision dates and should be distinguished from the four Fujifilm Corporation entries in this collection. [7][9]
Computed tomography filings
SCENARIA View Phase 6.0, filed as K261229, was received on April 15, 2026 and decided on September 18, 2026 as substantially equivalent under product code JAK. FCT iStream Phase 2, filed as K253836, was received on December 1, 2025 and decided on September 4, 2026, also under JAK. Both records describe the device as an x-ray computed tomography system, Class II, regulation 892.1750, with a summary statement included. [2][4]
What the record sample shows
The four-row record sample spans decision dates from September 4, 2026 to October 9, 2026, and every row in that sample carries a substantially equivalent decision. The full linked collection is also reported as four records, all under the 510(k) pathway with the same decision count. These figures describe the filings assembled as of November 20, 2026; they are not a measure of total company submissions, sales or safety performance. [1][2][3][4]
Published product description
Fujifilm Healthcare Americas Corporation’s product page describes Echelon Synergy as a 1.5T MRI system and identifies Synergy DLR as its Deep Learning Reconstruction technology, powered by artificial intelligence. These are the publisher’s product descriptions. The page states that Fujifilm makes no representation that products or services listed on the website are commercially available in all countries. [8]







